Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action
Xingchun Han(Roche (China)), Yang Song(Roche (China)), A. Mayweg(Roche (Switzerland)), Hassan Javanbakht(Harvard University), Souphalone Luangsay(Roche (Switzerland)), Xin Yu(Roche (China)), Hong C. Shen(Southern Medical University), Wenzhe Lv(Roche (China)), Zhanling Cheng(Roche (China)), Min Jiang(Roche (China)), Yongqiang Liu(Jilin University), Jianxun Xie(Unknown), Jianhua Wang(Nanjing University of Chinese Medicine), Yongguang Wang(Roche (China)), Jianping Wang(Translational Therapeutics (United States)), Min Wang(Zhongshan People's Hospital), Chungen Liang(Roche (China)), Zhanguo Wang(Roche (China)), Chengang Zhou(Roche (China)), Xue Zhou(Roche (China)), Robert J. Weikert(Roche (Switzerland))
Cited by 75
Related Papers
Recent advances in syntheses of heterocycles and carbocycles via homogeneous gold catalysis. Part 1: Heteroatom addition and hydroarylation reactions of alkynes, allenes, and alkenes
|Tetrahedron|2008|521
Recent advances in syntheses of carbocycles and heterocycles via homogeneous gold catalysis. Part 2: Cyclizations and cycloadditions
|Tetrahedron|2008|322
Ruthenium-Catalyzed Intramolecular [5 + 2] Cycloadditions
|Journal of the American Chemical Society|2000|237
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
|Journal of Medicinal Chemistry|2011|230